Plasma tricyclic drug levels in amitriptyline-treated depressed patients (original) (raw)
References
Alexanderson, B., Price Evans, D. A., Sjoquist, F.: Steady state levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Br. Med. J. 1969 I, 764–768
Biggs, J. T., Holland, W. H., Chang, S., Hipps, P. P., Sherman, W. R.: Electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma. J. Pharm. Sci. 65, 261–268 (1976) Google Scholar
Borga, O., Plafsky, K. M., Nilsen, O. G.: Plasma protein binding of basic drugs. I. Selective displacement from α1-acid glycoprotein by tris (2-butoxyethyl) phosphate. Clin. Pharmacol. Ther. 22, 539–544 (1977) Google Scholar
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1972 I, 1297–1299
Brunswick, D. J., Mendels, J.: Reduced levels of tricyclic antidepressants in plasma from Vacutainers. Comm. in Psychopharmacology 1, 131–134 (1977) Google Scholar
Brunswick, D. J., Needleman, B., Mendels, J.: Radioimmunoassay of imipramine and desmethylimipramine. Life Sci. 22, 137–146 (1978) Google Scholar
Brunswick, D. J., Needleman, B., Mendels, J.: Radioimmunoassay of amitriptyline and nortriptyline. Br. J. Clin. Pharmacol. (in press, 1979)
Burrows, G. D., Davies, B., Scoggins, B. A.: Plasma concentrations of nortriptyline and clinical response in depressive illness. Lancet 1972 II, 619–623
Burrows, G., Scoggins, B. A., Turecek, L. R., Davies, b.: Plasma nortriptyline and clinical response. Clin. Pharmacol. Ther. 16, 639–644 (1974) Google Scholar
Cooper, T. B., Allen, D., Simpson, G. M.: A sensitive method for the determination of amitriptyline and nortriptyline in human plasma. Psychopharmacol. Comm. 2, 105–116 (1976) Google Scholar
Cooper, T. B., Simpson, G. M.: Prediction of individual dosage of nortriptyline. Am. J. Psychiatry 135, 333–335 (1978) Google Scholar
Coppen, A., Ghose, K., Montgomery, S., Rama Raa, V. A., Bailey, J., Christiansen, S. J., Mikkleson, P. L., van Praag, H. M., van de Poel, F., Minsker, E. J., Kozulja, V. J., Matussek, N., Kungkunz, G., Jorgensen, A.: Amitriptyline plasma-concentration and clinical effect. Lancet 1978 I, 63–66
Cotham, R. H., Shand, D.: Spuriously low plasma propranolol concentrations resulting from blood collection methods. Clin. Pharmacol. Ther. 18, 535–538 (1975) Google Scholar
Derogatis, L. P., Lipman, R. S., Covi, L., Rickels, K.: Factorial invariance of symptom dimensions in anxious and depressive neuroses. Arch. Gen. Psychiatry 131, 168–171 (1972) Google Scholar
Downing, R. S., Rickels, K.: Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J. Nerv. Ment. Dis. 156, 109–129 (1973) Google Scholar
Fremstad, D., Bergerud, K.: Plasma protein binding of drugs as influenced by blood collection methods. Acta Pharmacol. Toxicol. 39, 570–572 (1976) Google Scholar
Gram, L. F.: Plasma level monitoring of tricyclic antidepressant therapy. Clin. Pharmacokinetics 2, 237–251 (1977) Google Scholar
Gram, L. F., Fredricson Overo, K.: Drug interaction: Inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br. Med. J. 1972 I, 463–465
Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56–62 (1960) Google Scholar
Hammer, W. M., Brodie, B. B.: Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic. anhydride. J. Pharmacol. Exp. Ther. 157, 503–508 (1967) Google Scholar
Kaul, P., Whitfield, L. R.: Demonstration of amitriptyline in blood levels following a single oral dose in humans. Proc. West. Pharmacol. Soc. 18, 251–255 (1976) Google Scholar
Khosla, T., Lowe, C. R.: Indices of obesity derived from body weight and height. Br. J. Prev. Soc. Med. 21, 122–128 (1967) Google Scholar
Kiloh, L. G., Ball, J. R. B., Garside, R. F.: Prognostic factors in treatment of depressive states with imipramine. Br. Med. J. 1962 I, 1225–1227
Klein, D. F., Davis, J. M.: Diagnosis and drug treatment of psychiatric disorders. Baltimore: Williams and Wilkins 1969 Google Scholar
Kupfer, D. J., Hanin, L., Spiker, D. G., Grau, G., Koble, P.: Amitriptyline plasma levels and clinical response in primary depression. Clin. Pharmacol. Ther. 22, 902–911 (1977) Google Scholar
Liisberg, P., Mose, H., Amdisen, A., Jorgensen, A., Hopfner Petersen, H. E.: A clinical trial comparing sustained release amitriptyline (Saroten® Retard) and conventional amitriptyline tablets (Saroten®) in endogenously depressed patients with simultaneous determination of serum levels of amitriptyline and nortriptyline. Acta Psychiatr. Scand. 57, 426–435 (1978) Google Scholar
Nies, A., Robinson, D. S., Friedman, J. M., Green, R., Cooper, T. B., Ravaris, C. L., Ives, J. O.: Relationship between age and tricyclic antidepressant plasma levels. Am. J. Psychiatry 134, 790–793 (1977) Google Scholar
Nies, A., Robinson, D. S., Lamborn, K. R., Ravaris, C. L., Ives, J. O.: The efficacy of the MAO inhibitor, phenelzine: dose effects and prediction of response. In: Neuropsychopharmacology, J. R. Boissier, H. Hippius, P. Pichot, eds., pp. 765–770. Amsterdam: Excerpta Medica 1975 Google Scholar
Oliver-Martin, R., Marzin, D., Buschenschutz, E., Pichot, P., Boissier, J.: Concentration plasmatiques de l'imipramine et de la desmethylimipramine et effect antidepresseur au cours d'un traitement controle. Psychopharmacologia 41, 187–195 (1975) Google Scholar
Perel, J., Shostak, M., Gann, E., Kantor, S. J., Glassman, A. H.: Pharmacodynamics of imipramine and clinical outcome in depressed patients. In: Pharmacokinetics of psychoactive drugs: blood levels and clinical response, L. S. Gottschalk and S. Merlis, eds., pp. 229–241. New York: Spectrum 1976 Google Scholar
Raskin, A., Schulterbrandt, J. G., Reatig, N., McKeon, J. J.: Differential response to chlorpromazine, imipramine and placebo. Arch. Gen. Psychiatry 23, 164–173 (1970) Google Scholar
Ravaris, C. L., Robinson, D. S., Ives, J. O., Nies, A., Bartlett, D.: A comparison of phenelzine and amitriptyline in the treatment of depression. (in preparation)
Reisby, N., Gram, L. F., Bech, P., Nagy, A., Petersen, G. O., Ortmann, J., Ibsen, I., Dencker, S. J., Jacobsen, O., Krautwald, O., Sondergaard, I., Christiansen, J.: Imipramine: clinical effects and pharmacokinetic variability. Psychopharmacology 54, 263–272 (1977) Google Scholar
Robinson, D. S., Lovenberg, W., Keiser, H., Sjoerdsma, A.: The effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem. Pharmacol. 17, 109–119 (1968) Google Scholar
Robinson, D. S., Nies, A., Ravaris, C. L.: The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states. Arch. Gen. Psychiatry 29, 407–413 (1973) Google Scholar
Robinson, D. S., Nies, A., Ravaris, C. L., Ives, J. O., Bartlett, D.: Clinical psychopharmacology of phenelzine: MAO activity and clinical response. In: Psychopharmacology: a generation of progress, M. A. Lipton, A. Di-Mascio and K. F. Killam, eds., pp. 961–973. New York: Raven 1977 Google Scholar
Robinson, D. S., Nies, A., Ravaris, C. L., Ives, J. O., Bartlett, D.: Clinical pharmacology of phenelzine. Arch. Gen. Psychiatry 35, 629–635 (1978) Google Scholar
Turner, W. J., Turano, P., Badzinski, S.: An attempt to establish quality control in determination of plasma chlorpromazine by a multilaboratory collaboration. In: Pharmacokinetics of psychoactive drugs: blood levels and clinical response, L. A. Gottschalk and S. M. Merlis, eds., pp. 33–42. New York: Spectrum 1976 Google Scholar
Ziegler, V. E., Co, B. T., Taylor, J. R., Clayton, P. J., Biggs, J. T.: Amitriptyline plasma levels and therapeutic response. Clin. Pharmacol. Ther. 19, 795–801 (1976) Google Scholar
Ziegler, V. E., Meyer, D. A., Rosen, S. H., Knesevich, J. W., Biggs, J. T.: Amitriptyline dosage schedule, sampling time and tricyclic plasma levels. Br. J. Psychiatry 131, 168–171 (1977) Google Scholar